What move does the options market price into Agenus's report?

Implied ±19.3%, either direction.

AGENNasdaqBiological Products, (No Diagnostic Substances)

Agenus Inc (AGEN) earnings date, market-implied expected move, and options open interest by expiry

6.92

+0.25 · +3.68%

Regular session11:32 ET

Open6.68Volume499,036Mkt cap$300.3MP/E3.11EPS2.22

Day6.68 – 6.9586%52-wk2.71 – 10.3155%

AGEN

Agenus Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±19.3%implied · report alone

8Q avg ±10.8%·×1.78·rich

5.387.96

straddle ±21.3%

spot 6.67exp Nov 20ATM strike 7ATM straddle 1.67IV 141%

Nov 3 closereport share · term structure

Expected move

Inputs

Next report

Nov 9

before open · in 5 days

est.Q3 FY26

Calendar

Next report

Last report

−3.73%

vs ±17.0% implied · ×0.22

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Largest filed tie

5.00%

of AGEN revenue · Zydus Lifesciences

customerAGEN 10-K

Supply chain

Largest filed tie

13F top-10 QoQ

+64.31%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

103 managers

Top fund weight

0.00%

AGEN weight · UWM

N-PORTAug 31 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Agenus (AGEN) is expected to report on Nov 9 before open (estimated date).

Implied vs realized

8 reports

—≥ implied

Nov 12 '24Nov 12 '24confirmed—▼−20.38%—

Mar 11 '25Mar 11 '25confirmed—▼−4.65%—

May 12 '25May 12 '25confirmed—▲+20.27%—

Aug 11 '25Aug 11 '25confirmed—▼−11.04%—

Q3 FY25Nov 10 '25confirmed—▲+5.78%—

Q1 FY26Mar 16 '26confirmed—▲+6.13%—

May 11 '26May 11 '26confirmed—▼−14.66%—

Q2 FY26Aug 6 '26confirmed±17.0%▼−3.73%×0.22

quarterimplied−25%0+25%realized×

Q2 FY26±17.0%▼−3.73%×0.22

May '26—▼−14.66%—

Q1 FY26—▲+6.13%—

Q3 FY25—▲+5.78%—

Aug '25—▼−11.04%—

May '25—▲+20.27%—

2 older reports

Mar '25—▼−4.65%—

Nov '24—▼−20.38%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Oct 30 close

0.58OI · 4 expiries · Oct 30 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

2,236−1%Nov 2016d3,853+1%

0—Dec 1844d0.0027+800%0.00

1,2920%Jan 1572d0.264,9350%0.26

98+11%Feb 19107d0.156390%0.15

ExpiryPutsCallsP/C

Nov 2016d2,236−1%3,853+1%0.58

Dec 1844d0—27+800%0.00

Jan 1572d1,2920%4,9350%0.26

Feb 19107d98+11%6390%0.15

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±21.3%

Funds 3

UWM±0.0%

IWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

−1.64%as filednet margin · revenue +2.32% QoQ · +34.36% YoY

Revenue$35M+2.32%

Gross profit$35M100.00%+2.32%

Operating income$11M32.72%−24.98%

Pre-tax income−$3M−107.63%

Net income−$567,000−1.64%−101.45%

Cost of revenue$0—

Operating expenses$23M+207.04%

Other expense−$14M+3.30%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 3 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 11:30 ET

Intraday

Event sensitivity

CPI ×1.08· ±5.2% vs ±4.8% · 10 releases

eventrelease day|move|up · n×base

CPIconsumer prices±5.2%5 of 10×1.08

PPIproducer prices±4.1%6 of 10×0.87

GDPgross domestic product±4.1%6 of 19×0.86

PCEpersonal income & outlays±3.9%7 of 19×0.81

CPROFcorporate profits±3.1%3 of 12×0.66

FOMCrate decision±3.0%11 of 24×0.64

NFPjobs report±2.5%6 of 10×0.53

Bar = avg |move| to ±6% · tick = ±4.8% avg day · ×base = |move| ÷ ±4.8% · min 6 releases

Earnings history

EPS -0.01 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	-0.01	—
Q1 FY26	Mar 16 '26 · confirmed	1.02	—
Q3 FY25	Nov 10 '25 · confirmed	1.94	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod